<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD09630000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q8IWV8</UniProt_ID>
  <Seq_Length>1755</Seq_Length>
  <Molecule_Weight>200538</Molecule_Weight>
  <KEGG_ID>hsa:23304</KEGG_ID>
  <Orthology_ID>K10626</Orthology_ID>
  <EBI_ID>EBI-1237260</EBI_ID>
  <Function_Summary>E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. Plays a critical role in chromatin inactivation and chromosome-wide transcriptional silencing during meiosis via ubiquitination of histone H2A. Binds leucine and is a negative regulator of the leucine-mTOR signaling pathway, thereby controlling cell growth.</Function_Summary>
  <Pfam_ID>PF02617:ClpS@@PF02207:zf-UBR</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Ubiquitin-protein ligase E3-alpha-II</Alias>
      <Alias>Ubiquitin-protein ligase E3-alpha-2</Alias>
      <Alias>N-recognin-2</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with zinc (Zn) ions.</Detail>
      <Keyword>Zinc ion binding</Keyword>
      <Ontology_ID>GO:0008270</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + ubiquitin + protein lysine = AMP + diphosphate + protein N-ubiquityllysine.</Detail>
      <Keyword>Ubiquitin-protein ligase activity</Keyword>
      <Ontology_ID>GO:0004842</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the joining of two substances, or two groups within a single molecule, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.</Detail>
      <Keyword>Ligase activity</Keyword>
      <Ontology_ID>GO:0016874</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with 2-amino-4-methylpentanoic acid.</Detail>
      <Keyword>Leucine binding</Keyword>
      <Ontology_ID>GO:0070728</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>1095</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>1095</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>1095</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>172</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The modification of histone H2A by addition of one or more ubiquitin groups.</Detail>
      <Keyword>Histone H2A ubiquitination</Keyword>
      <Ontology_ID>GO:0033522</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leucine stimulus.</Detail>
      <Keyword>Cellular response to leucine</Keyword>
      <Ontology_ID>GO:0071233</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cell cycle process comprising the steps by which a cell progresses through male meiosis I, the first meiotic division in the male germline.</Detail>
      <Keyword>Male meiosis I</Keyword>
      <Ontology_ID>GO:0007141</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Repression of transcription by altering the structure of chromatin, e.g. by conversion of large regions of DNA into an inaccessible state often called heterochromatin.</Detail>
      <Keyword>Chromatin silencing</Keyword>
      <Ontology_ID>GO:0006342</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.</Detail>
      <Keyword>Spermatogenesis</Keyword>
      <Ontology_ID>GO:0007283</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in ubiquitin-like modifier processing, activation, conjugation or deconjugation such as Ubl-activating enzymes (E1s), Ubl-conjugating enzymes (E2s), Ubl-protein ligases (E3s), some thiol proteases (Ubiquitin carboxyl-terminal hydrolases (UCH), Ubiquitin-specific processing proteases (UBP) and ubiquitin-like proteases) and the ubiquitin-like modifier proteins. Besides signaling proteolysis, ubiquitination for example can be a signal for trafficking, kinase activation and other nonproteolytic fates.</Detail>
      <Keyword>Ubl conjugation pathway</Keyword>
      <Ontology_ID>KW-0833</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein.</Detail>
      <Keyword>Ubiquitin-dependent protein catabolic process</Keyword>
      <Ontology_ID>GO:0006511</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of signaling via the TOR signaling pathway.</Detail>
      <Keyword>Negative regulation of TOR signaling cascade</Keyword>
      <Ontology_ID>GO:0032007</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MASELEPEVQAIDRSLLECSAEEIAGKWLQATDLTREVYQHLAHYVPKIYCRGPNPFPQKEDMLAQHVLLGPMEWYLCGEDPAFGFPKLEQANKPSHLCGRVFKVGEPTYSCRDCAVDPTCVLCMECFLGSIHRDHRYRMTTSGGGGFCDCGDTEAWKEGPYCQKHELNTSEIEEEEDPLVHLSEDVIARTYNIFAITFRYAVEILTWEKESELPADLEMVEKSDTYYCMLFNDEVHTYEQVIYTLQKAVNCTQKEAIGFATTVDRDGRRSVRYGDFQYCEQAKSVIVRNTSRQTKPLKVQVMHSSIVAHQNFGLKLLSWLGSIIGYSDGLRRILCQVGLQEGPDGENSSLVDRLMLSDSKLWKGARSVYHQLFMSSLLMDLKYKKLFAVRFAKNYQQLQRDFMEDDHERAVSVTALSVQFFTAPTLARMLITEENLMSIIIKTFMDHLRHRDAQGRFQFERYTALQAFKFRRVQSLILDLKYVLISKPTEWSDELRQKFLEGFDAFLELLKCMQGMDPITRQVGQHIEMEPEWEAAFTLQMKLTHVISMMQDWCASDEKVLIEAYKKCLAVLMQCHGGYTDGEQPITLSICGHSVETIRYCVSQEKVSIHLPVSRLLAGLHVLLSKSEVAYKFPELLPLSELSPPMLIEHPLRCLVLCAQVHAGMWRRNGFSLVNQIYYYHNVKCRREMFDKDVVMLQTGVSMMDPNHFLMIMLSRFELYQIFSTPDYGKRFSSEITHKDVVQQNNTLIEEMLYLIIMLVGERFSPGVGQVNATDEIKREIIHQLSIKPMAHSELVKSLPEDENKETGMESVIEAVAHFKKPGLTGRGMYELKPECAKEFNLYFYHFSRAEQSKAEEAQRKLKRQNREDTALPPPVLPPFCPLFASLVNILQSDVMLCIMGTILQWAVEHNGYAWSESMLQRVLHLIGMALQEEKQHLENVTEEHVVTFTFTQKISKPGEAPKNSPSILAMLETLQNAPYLEVHKDMIRWILKTFNAVKKMRESSPTSPVAETEGTIMEESSRDKDKAERKRKAEIARLRREKIMAQMSEMQRHFIDENKELFQQTLELDASTSAVLDHSPVASDMTLTALGPAQTQVPEQRQFVTCILCQEEQEVKVESRAMVLAAFVQRSTVLSKNRSKFIQDPEKYDPLFMHPDLSCGTHTSSCGHIMHAHCWQRYFDSVQAKEQRRQQRLRLHTSYDVENGEFLCPLCECLSNTVIPLLLPPRNIFNNRLNFSDQPNLTQWIRTISQQIKALQFLRKEESTPNNASTKNSENVDELQLPEGFRPDFRPKIPYSESIKEMLTTFGTATYKVGLKVHPNEEDPRVPIMCWGSCAYTIQSIERILSDEDKPLFGPLPCRLDDCLRSLTRFAAAHWTVASVSVVQGHFCKLFASLVPNDSHEELPCILDIDMFHLLVGLVLAFPALQCQDFSGISLGTGDLHIFHLVTMAHIIQILLTSCTEENGMDQENPPCEEESAVLALYKTLHQYTGSALKEIPSGWHLWRSVRAGIMPFLKCSALFFHYLNGVPSPPDIQVPGTSHFEHLCSYLSLPNNLICLFQENSEIMNSLIESWCRNSEVKRYLEGERDAIRYPRESNKLINLPEDYSSLINQASNFSCPKSGGDKSRAPTLCLVCGSLLCSQSYCCQTELEGEDVGACTAHTYSCGSGVGIFLRVRECQVLFLAGKTKGCFYSPPYLDDYGETDQGLRRGNPLHLCKERFKKIQKLWHQHSVTEEIGHAQEANQTLVGIDWQHL</Protein_Seq>
    <DNA_Seq>GGACGCGGTAGTGGCCAGCGAGAGTGTCAGGCCTGGGGTTTTCTGTGTCCTTCCCTGGGTCAGGGACGAGCCAGTGACTTGACTCTTGGGCGCTAAGCTTGGGAGGGAGCGCAGGAGGCCGCTGTCCTTCCTTTCCGGTTCACGTCACCCTTCTCTCCCTCTGTTGCTCCACCTGCAGCCACTTGGACGGCTCCGGGACTGATTGCCTGGGGCAGGGGTGGCAGTCGAGGCCGCCGGGGCCGAGGTGAGGCTGCAGCTCTCCGGGCGGCGGTAGCGCTGGGGAGGAGGAGGAGAGAAGATGGCGTCGGAGCTAGAGCCAGAGGTGCAGGCCATCGACCGGAGCTTGCTGGAATGTTCGGCCGAGGAGATTGCGGGGAAATGGCTGCAAGCAACTGACCTCACTAGAGAAGTGTACCAGCATTTAGCCCACTATGTACCCAAAATCTACTGCAGGGGTCCCAACCCTTTTCCACAGAAAGAAGACATGCTGGCACAGCATGTTTTGTTGGGACCAATGGAATGGTACCTTTGTGGTGAAGATCCTGCATTTGGATTTCCAAAACTTGAGCAAGCAAACAAACCTTCTCATCTTTGTGGTCGTGTTTTTAAAGTAGGAGAGCCTACATATTCTTGCAGAGACTGTGCAGTTGATCCAACTTGTGTTTTGTGCATGGAGTGCTTTTTGGGAAGTATTCACAGAGATCATCGATATAGGATGACAACATCAGGAGGTGGAGGTTTCTGTGACTGTGGTGATACTGAAGCCTGGAAAGAGGGTCCTTACTGTCAAAAACATGAACTTAACACCTCTGAAATTGAGGAAGAAGAGGATCCTCTTGTTCATTTATCAGAAGATGTGATAGCAAGAACTTATAACATTTTTGCTATTACGTTTCGGTATGCAGTAGAAATATTAACCTGGGAAAAAGAAAGTGAATTGCCAGCAGATTTAGAGATGGTAGAGAAGAGTGACACCTACTATTGCATGCTGTTTAATGATGAGGTTCACACCTATGAACAAGTTATTTATACTCTTCAGAAAGCTGTTAACTGTACACAAAAAGAAGCTATTGGTTTTGCAACTACAGTAGATCGAGATGGGCGTAGGTCTGTTCGATATGGAGATTTTCAGTATTGTGAGCAAGCAAAATCAGTAATTGTGAGAAATACCAGTAGACAGACAAAGCCACTCAAAGTTCAAGTTATGCATTCGTCTATTGTCGCACATCAGAATTTTGGTTTGAAACTTTTGTCTTGGCTGGGAAGTATTATTGGATATTCAGATGGCCTTCGCCGGATTTTATGTCAAGTTGGTTTACAAGAAGGGCCAGATGGTGAAAACTCTTCTCTAGTGGACAGACTGATGCTTAGTGATTCCAAATTATGGAAAGGTGCTAGGAGTGTATATCATCAGTTGTTCATGAGCAGTCTGCTTATGGATTTGAAATACAAGAAACTATTTGCTGTTCGATTTGCAAAAAACTATGAGCGTTTGCAGAGTGATTATGTGACAGATGACCACGACAGAGAGTTTTCAGTCGCAGACCTCTCGGTTCAGATATTCACGGTTCCTTCACTTTTCTCTATCTCTGCTGGGCGCAGTGGCTCACCTCTGTAATCCTAGCCAAGGCAGGTGGATCACCTGAGCTTAGGAGTCTGAGACCAGCCTGGCCAACATGGTGAAACCCCATCTCTACTAAAAATAGAAAAATTAGCCAGGCGTGGTGGCGCACGCCTGAGGCTGAGGCAGAAGAATCACTTGAACCCAAGAGGCGGAGGTTGCAGTGAGCTGAGATCAAGCCATTGCACTCCAGCCTGGGCGACAGAGCGAGATTCGGTATCCAAAAAAAAAAAGTTCTTGCTCTGTCACTCAGGCTGGAGTGAGGTGGCACGATCACAGCTCACTGCAGCTTTGACCACCTGGGCTTAGGCAATCCTCCTGTCTCAGCCTCCCAAGTAGCTGGGACCACAGATGCATGCCACCACACCCAGCTAGTCTTAACATTTTTAAATTAAGCTTATATGGTTTATATTTTTGATGCTGTAGTAAACTTTTTATATTTTTGATGCTGTAGTAAACTTTTTATATTTTTAAACAGGCTATGGTAGTATTTAGGAAAACTACTGATTTTTATATGTCCATCTTATATCTGTCTGGTCTATCTGGATATGTATGTATTCAGATTAAATAGGTTCTACCAGACTCTTTTCCATAATGGTTAAACCAATTCATGCTTCTGTTAATAACGTATGAAAGTGATAGTTGCTCCACATCCTCACCAACACTTGGTTTTACCAGTCTTTTAAGATTTTATCTATTCTAGTGGGACATAGTGGTTTCTCATTATGGTTTTAATTTGCATTCTTCTGATGATGATGAAGCTGAATTCCTTTTTATATGTTTATTGGCATTTGGATATACTCCTTTGTGAATCCCTGTTAAAGTTGTCCTTTGATTATCTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Widely expressed </TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Chromatin</CellLocal>
      <Ontology_ID>GO:0000785</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Ubiquitin ligase complex</CellLocal>
      <Ontology_ID>GO:0000151</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>UBR2</Gene_Name>
    <Gene_Alias>C6orf133; KIAA0349</Gene_Alias>
    <Gene_ID>23304</Gene_ID>
    <Genbank_ACCN>NM_001184801</Genbank_ACCN>
    <Protein_ACCN>NP_001171730</Protein_ACCN>
    <HGNC_ID>21289</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/23304</Gene_URL>
    <UCSC_ID>uc011dus.2</UCSC_ID>
    <EMBL_ID>ENSG00000024048</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P12504</Uniprot_ID>
      <Gene_Name>vif</Gene_Name>
      <EBI_ID>EBI-779991</EBI_ID>
      <PPI_EBI_URL>EBI-1237260,EBI-779991</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Rapadilino Syndrome</Disease_Name>
      <Disease_Detail>Rapadilino Syndrome</Disease_Detail>
      <Disease_DB>RPD002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/rapadilino_syndrome?search=UBR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Johanson-Blizzard Syndrome</Disease_Name>
      <Disease_Detail>Johanson-Blizzard Syndrome</Disease_Detail>
      <Disease_DB>JHN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/johanson_blizzard_syndrome?search=UBR2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Structure of the ubr-box of UBR2 ubiquitin ligase</PDB_Title>
      <PDB_ID>3NY2</PDB_ID>
      <Resolution>2.61</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NY2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of substrate recognition and specificity in the N-end rule pathway.</PubMed_Title>
      <Author>Matta-Camacho, E., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2010)17:1182-1187</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20835242?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of the ubr-box of UBR2 in complex with N-degron</PDB_Title>
      <PDB_ID>3NY3</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NY3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of substrate recognition and specificity in the N-end rule pathway.</PubMed_Title>
      <Author>Matta-Camacho, E., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2010)17:1182-1187</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20835242?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>An JY, et al. PLoS One. 2012;7(5):e37414.</Site_Reference>
      <Site_Type>Peptides-induced </Site_Type>
      <PubMed_ID>22616001</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>6.3.2.-</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC6/3/2/-.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2013-04-23</Create_Date>
</Organism_Record>